2019 Walk to Cure Arthritis Honorees

 

Orly Abel
Juvenile Arthritis
Youth Honoree  


Orly Abel is 11 years old and has been battling juvenile arthritis for nearly 10 years, which means that she has to go to the doctors often and has had to miss a lot of school. The Walk to Cure Arthritis - New York City event means so much to Orly because it raises funds that allow doctors and scientists the opportunity to do research to find a cure for arthritis. She is so happy that this event happens each year and that her team and all of the other walk teams are able to raise money and meet other people who have similar stories and are dealing with the same disease. Orly is very excited to be the 2019 Walk to Cure Arthritis - New York City Youth Honoree and is looking forward to meeting and connecting with lots of other arthritis warriors and their families! Orly invites everyone to join her at the Intrepid Air and Space Museum on Sunday, June 2 as we Walk to Cure Arthritis!


Mallory Rosen
Juvenile Rheumatoid Arthritis
Adult Honoree  


 Team MALLERINA is back! Mallory is excited to be the 2019 Walk To Cure Arthritis Adult Honoree!

Since last year's walk, Mallory has gotten more involved with the Arthritis Foundation and has found it to be such a source of community and strength. She sits on committees for the Walk as well as the new Women on the Move Luncheon. Mallory plans on creating the first ever Young Professionals Committee.

Mallory grew up as a ballerina and is one at heart. She was given the nickname Mallerina during her summer camp days. One morning at just 12 years old, she woke up with fever and her left knee was as swollen as a grapefruit.

Countless doctors’ appointments, blood drawings, X-rays, CT scans, MRIs, bone scans followed until she was finally diagnosed with Juvenile Rheumatoid Arthritis, a chronic debilitating disease that 300,00 kids in America have.

Mallory's life took plenty of unexpected twists and turns. She had to quit dancing. She had 4 knee surgeries and 1 hip surgery before the age of 21. The challenges of her RA affected her overall quality of life. Her immune system was very weak from TNF inhibitors that she battled pneumonia and MRSA within 6 months. Mallory was eventually able to conquer her RA with the proper medications, which have slowed the progression of her disease.

Mallory is the voice for those living with RA and their families. She is proud to be a representative of the RA community, especially for Juvenile Rheumatoid Arthritis.

Mallory is proud to lead Team MALLERINA at Walk To Cure Arthritis 2019 in New York City. Her mission is to increase arthritis awareness that #KIDSGETITTOO. She hopes for a cure in the future.

Please join Team MALLERINA in our fight to conquer arthritis and donate to this important cause.


Mary K. Crow, M.D.
Hospital for Special Surgery
Medical Honoree  


Mary K. Crow, M.D. received her M.D. from Cornell University Medical College in 1978, Internal Medicine and Rheumatology subspecialty training at New York Hospital and Hospital for Special Surgery, and post-doctoral research training at Rockefeller University in the laboratory of Dr. Henry Kunkel. Dr. Crow is Physician-in-Chief and Chair of the Department of Medicine at Hospital for Special Surgery, Professor of Medicine and Chief of the Rheumatology Division at Weill Cornell Medical College, and Professor of Immunology in its Graduate School of Medical Sciences. She is the Joseph P. Routh Professor of Rheumatic Diseases in Medicine at the medical college. Dr. Crow is also Senior Scientist, Co-Director of the Mary Kirkland Center for Lupus Research, and Director of the Autoimmunity and Inflammation Program in the Research Division of Hospital for Special Surgery where she holds the Benjamin M. Rosen Chair in Immunology and Inflammation Research.

Dr. Crow’s research has focused on the induction and regulation of human autoimmune diseases. She was among the first to characterize the functional properties of human dendritic cells and has studied self-reactive T cells in the prototype systemic autoimmune diseases, systemic lupus erythematosus and rheumatoid arthritis. She continues to investigate the underlying triggers of autoimmune disease and the cellular and cytokine mediators of immune system activation and inflammation in those disorders. She has been a leader in the identification of the central role of type I interferon in the pathogenesis of systemic autoimmune diseases.

Dr. Crow was President of the American College of Rheumatology from 2005-2006. She is also a past president of the Henry Kunkel Society and is Co-Chair of the Scientific Advisory Board of the Alliance for Lupus Research. She is a member of the Board of Trustees of Hospital for Special Surgery and of the Arthritis Foundation, New York Chapter. Dr. Crow was named an “Arthritis Hero” by the Arthritis Foundation in 2001 and received the Margaret D. Smith Lifetime Achievement Award of the Arthritis Foundation, New York Chapter, in 2010. In 2017 Dr. Crow was one of only two American physicians to be named an honorary member of the European League Against Rheumatism, and in 2018 she received the Presidential Gold Medal of the American College of Rheumatology in recognition of outstanding achievements in rheumatology over an entire career.